Technical Analysis for HQL - H&Q Life Sciences Investors

Grade Last Price % Change Price Change
D 14.65 0.62% 0.09
HQL closed up 0.62 percent on Friday, November 1, 2024, on 84 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
1 Watcher
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Down Down

Date Alert Name Type % Chg
Bollinger Band Squeeze Range Contraction 0.00%
Lower Bollinger Band Walk Weakness 0.00%
BB Squeeze + Lower Band Touch Range Contraction 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Oversold Stochastic Weakness 0.00%
Bollinger Band Squeeze Range Contraction 0.62%
Stochastic Reached Oversold Weakness 0.62%
BB Squeeze + Lower Band Touch Range Contraction 0.62%
Below Lower BB Weakness 0.62%
Down 3 Days in a Row Weakness 0.62%

   Recent Intraday Alerts

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

H&Q Life Sciences Investors Description

H&Q Life Sciences Investors is a close ended equity mutual fund launched and managed by Hambrecht & Quist Capital Management, LLC. The fund invests in the public equity markets across the globe. It invests in stocks of companies operating in the health technology and life sciences industries. It also invests in stocks of early and later stage financings of privately held companies, private placements by public companies. The fund invests in growth stocks of companies operating across all market capitalizations. It employs fundamental analysis with a focus on factors such as potential for above-average, long-term growth in revenues and earnings securities strong market position for their services or products, experienced business management, and, recognized technological expertise. The fund benchmarks the performance of its portfolio against the NASDAQ Biotech Index and the S&P 500 Index. H&Q Life Sciences Investors was formed on February 20, 1992 and is domiciled in the United States.


Classification

Sector: Financial Services
Industry: Asset Management
Keywords: Stock Fund Business Management Health Technology Nasdaq Biotech Experienced Business Management

Is HQL a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 15.684
52 Week Low 10.3549
Average Volume 67,808
200-Day Moving Average 13.71
50-Day Moving Average 15.05
20-Day Moving Average 14.93
10-Day Moving Average 14.89
Average True Range 0.19
RSI (14) 38.65
ADX 24.24
+DI 13.17
-DI 32.33
Chandelier Exit (Long, 3 ATRs) 14.70
Chandelier Exit (Short, 3 ATRs) 15.09
Upper Bollinger Bands 15.24
Lower Bollinger Band 14.62
Percent B (%b) 0.05
BandWidth 4.16
MACD Line -0.08
MACD Signal Line -0.04
MACD Histogram -0.0397
Fundamentals Value
Market Cap 392.49 Million
Num Shares 26.8 Million
EPS 0.79
Price-to-Earnings (P/E) Ratio 18.54
Price-to-Sales 107.46
Price-to-Book 0.92
PEG Ratio 0.00
Dividend 1.30
Dividend Yield 8.87%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 14.91
Resistance 3 (R3) 14.90 14.80 14.87
Resistance 2 (R2) 14.80 14.74 14.81 14.85
Resistance 1 (R1) 14.73 14.70 14.77 14.74 14.84
Pivot Point 14.63 14.63 14.65 14.63 14.63
Support 1 (S1) 14.55 14.56 14.59 14.56 14.46
Support 2 (S2) 14.45 14.52 14.46 14.45
Support 3 (S3) 14.38 14.45 14.43
Support 4 (S4) 14.39